Jiangxi Kewei Pharmaceutical

Jiangxi Kewei Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing subsidiary of the HEC Group (Dongyangguang), located in Xinyu, Jiangxi Province, China. The company serves as a core production base for the group's chemical drug division, focusing on the large-scale manufacture of anti-infectives, antivirals, and metabolic disease medications. Its state-of-the-art facilities are GMP-certified for the production of various oral dosage forms, including tablets, capsules, and granules. Jiangxi Kewei is responsible for the commercial supply of several key products, such as the antibiotics clarithromycin and azithromycin, and the uricosuric agent benzbromarone. As an integral part of HEC's pharmaceutical supply chain, the company supports the group's extensive distribution network across China.